Why is Aristo Bio-Tech falling/rising?

As of 28-Aug, Aristo Bio-Tech & Lifescience Ltd is currently priced at 120.60, with no change in price (0.00%). The stock has shown a performance today that outperformed its sector by 1.22%. However, it is important to note that while the stock is higher than its 5-day and 20-day moving averages, it remains lower than its 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant decline in investor participation, with delivery volume dropping by 50% compared to the 5-day average. In terms of returns, the stock has increased by 8.55% over the past week, while it has seen a slight decline of 0.41% over the past month. Year-to-date, the stock is down 9.32%, contrasting with a 3.62% increase in the Sensex.
In the broader market context, the stock's recent performance has been relatively strong compared to the benchmark, as it outperformed the Sensex by a notable margin of 10.87% over the past week. However, over the longer term, the stock has underperformed the benchmark year-to-date and is also down slightly over the past month. The overall market sentiment appears to be mixed, with the Sensex declining by 2.32% over the past week, while Aristo Bio-Tech has managed to gain. This suggests that despite some positive short-term movements, the stock's longer-term performance remains a concern, particularly given the falling investor participation and liquidity issues.